Subject: TPNI Up 40% on News PSID Earnings Out PZOO New Radio

SCV Client Spotlight
TPNI Up 40% on News PSID Earnings Out PZOO New Radio
Hot Stock to WatchHot Stock to Watch

Company: The Pulse Network Inc. (OTCQB: TPNI)

End of Day:

Price: 0.025

Change (%): - 0.005 (16.67)

Volume: 36,000
TPNI Chart

The Pulse Network Celebrates 50 Best Selling Authors Created With the Launch of Their Publish & Profit Course

NORWOOD, Mass., Nov. 19, 2014 (GLOBE NEWSWIRE) - The Pulse Network, Inc. (TPNI), a digital marketing platform company, is celebrating the 30-day benchmark of its Publish & Profit launch with the news of helping create over 50 new best selling authors on Amazon Books. Publish & Profit is a proven “Integrated Hybrid Publishing System” embraced by small business owners, Literary Agents, NY Times Bestselling authors, experts, speakers, consultants, coaches and entrepreneurs delivered as proven, easy, 5 step process interactively and online. Members learn how to create and market their book by learning the 5 P’s: Prepare, Perform, Publish, Promote and Profit.

This product launch marks the first successful product launch campaign since the integration of Instant Customer and Traffic Geyser into The Pulse Network. With each successful product launch, The Pulse Network introduces itself and its software platform to new clients while educating the Instant Customer community.

Continue Reading

Top PerformerYesterday's Top Performer

BioCorRx Inc. (OTCQB: BICX)

End of Day:

Price: 0.1169

Change (%): + 0.0169 (16.90)

Volume: 137,985
BICX Chart

About BioCorRx, Inc.

BioCorRx, Inc. (OTCQB:BICX) is an addiction treatment and rehabilitation company on the leading edge of substance abuse addiction treatment. The company has developed a highly effective program called the Start Fresh ProgramTM consisting of two components used by various addiction clinics in the US. Clinic reports show that the treatment program has an extremely high success rate with individuals that complete the program. The first component of the program consists of an outpatient implant procedure performed by a licensed physician that delivers therapeutic levels of the drug Naltrexone, an opioid antagonist that significantly reduces physical cravings for alcohol and opioids, into the body. The second component of the program developed by BioCorRx, Inc. is a one on one coaching program specifically tailored for the treatment of alcoholism and other substance abuse addictions.

Company Information Sheet

SmallCapVoice Clients' News

PositiveID Corporation (OTCQB: PSID)

PositiveID Corporation Announces Third Quarter 2014 Results

Company Reports Revenue; Ships Multiple M-BAND Units for Testing Under Government Contract for Improved Biosurveillance; Accelerates Development of Firefly Dx Handheld Diagnostic Device

DELRAY BEACH, Fla., Nov. 19, 2014 (GLOBE NEWSWIRE) - PositiveID Corporation (“PositiveID” or “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, announced today its highlights for the third quarter ended September 30, 2014, and also filed its Form 10-Q, which can be found at:

William J. Caragol, Chairman and CEO of PositiveID, said, “I am very pleased to report again that we generated revenue in the quarter and, more notably, to remind our investors of the significant progress we have made in 2014 to achieve the goals we set for ourselves related to both M-BAND and Firefly Dx. We are proud of the agreements we have entered into with world-class commercial and government partners, and their implicit validation of our technology and team. We believe that our accomplishments to date position us well for continued success through the end of 2014 and into 2015.”

Continue Reading

Company: Pazoo Inc. (OTCQB: PZOO)

Pazoo Radio Episode 5 Healthy Investing: Healthy Ways To Cope With Scary News -- From Terrorism to Ebola -- With Diane Lang

WHIPPANY, N.J., Nov. 19, 2014 /PRNewswire/ - Pazoo, Inc. (OTCQB Symbol: PZOO) (German WKN#: A1J3DK) is pleased to announce Pazoo Radio Episode 5 is now available for download at by clicking on the Pazoo Radio tab on the upper right hand side of the home page. On this episode, Pazoo CEO David Cunic teams up with co-host Chris Curran of Fractal Recording for a timely and important discussion with Positive Living Expert, Life Coach & Professional Speaker Diane Lang. Diane is President of DL Counseling and is’s Psychology/Happiness Expert.

Pazoo Radio Episode 5 focuses on something that impacts all of us - some much harder than others - and especially young children: the constant exposure to frightening news about terrorism, war, school shootings, money-issues, and now Ebola. All this compounded with the short days and long cold nights can truly bring on those cold winter blues.

Continue Reading

Other Small Cap News

Company: Guided Therapeutics, Inc. (OTCBB/QB: GTHP)

Guided Therapeutics Reports Third Quarter 2014 Results

NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB/QB: GTHP) today announced its operating results for the third quarter and nine months ended September 30, 2014.

“LuViva revenues continue to build sequentially, with an increase of 30% from the second quarter and a 351% increase from the year ago period,” said Gene Cartwright, Chief Executive Officer of Guided Therapeutics. “We shipped a total of 13 units in the quarter along with over 5,000 high margin disposable Cervical Guides. Markets that received shipments of LuViva devices in the quarter include Guatemala, Bangladesh, Mexico, Turkey, Kenya and Nigeria. Depending on timing of fourth quarter shipments, we should approach product sales toward the low end our projections of approximately 1 million dollars for 2014.”

Continue Reading

Market News

By Tom DiChristopher: CNBC

Markets are in for a bumpier ride: Bob Doll

Markets are in for a bumpy ride compared to the low-volatility environment of recent history, strategist Bob Doll told CNBC on Wednesday.

The recent pullback is a sign that volatility is heading back toward normal, the chief equity strategist at Nuveen Asset Management said on "Squawk Box."

"I think the trend is up, but it's going to be a bumpier ride than the last several years, where with 20/20 hindsight it was pretty easy," he said.

Continue Reading

By Jeff Macke:
Yahoo Finance

Nasdaq going to 5000, No it's not a bubble: Macke

Stocks are looking a little weaker this morning after yesterday's strong rally. It's still pretty quiet though which makes this a good day to back up and take a slightly longer-term look. Specifically, I want to address two ideas: First, can the Nasdaq (^IXIC) hit 5,000 this year and second, does that mean we are in another bubble?

The answer to the first question is yes, of course the Nasdaq can hit 5,000. If it does not happen this year it can certainly do it early next year if only on the basis of momentum and the gravitational pull of big round numbers. The famously tech-laden index is just 6.4% from highs we have not seen in almost a generation. That seems like a lot but keep in mind the Nasdaq is already up 15.9% for the year, almost all of that since mid October.

Since 1971 the average return for the Nasdaq in November is 1.56%. December comes in at 2% and January, the best month of the year, at a 2.7% average return for 43 years.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks